Pureos Bioventures
9 portfolio companies · 3 on the map · $430.5M raised · 3 cities
Portfolio map
3 Pureos Bioventures portfolio companies on the map.
Portfolio companies
Alentis Therapeutics
Allschwil
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Pharmaceutical Manufacturing$365.4MEst. 2019
Ariceum Therapeutics
Berlin
Ariceum Therapeutics is a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. The name Ariceum is an anagram of ‘Marie Curie’ whose discovery of radium and polonium have been huge contributions to finding treatments for cancer. Ariceum’s lead targeted systemic radiopharmaceutical candidate, SSO110 (“satoreotide”) labelled with Lutetium-177 (177Lu) and Actinium-255 (255Ac) is an antagonist of the somatostatin type 2 (SSTR2) receptor which is overexpressed in aggressive neuroe
Biotech$47.8MEst. 2021
AnaCardio
Stockholm
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Biotech$17.3M
More portfolio companies
5 more Pureos Bioventures investments we track beyond the map — 9 tracked in total.
Portfolio map
3 Pureos Bioventures portfolio companies on the map.